Edmond de Rothschild Asset Management (France)’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-6,450
Closed -$279K 247
2015
Q3
$279K Buy
+6,450
New +$272K 0.01% 191

Other funds holding WX

Edmond de Rothschild Asset Management (France)'s WX Position: Q4 2015 in Review

Edmond de Rothschild Asset Management (France) sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 6,450 shares — an estimated $279K sold.

Edmond de Rothschild Asset Management (France) first reported a position in WX in Q3 2015 and held it in 1 quarter. The position peaked at $279K in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Edmond de Rothschild Asset Management (France) reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Edmond de Rothschild Asset Management (France) sold 6,450 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $279K.
  • Edmond de Rothschild Asset Management (France) first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2015 and held it in 1 quarter.
  • Edmond de Rothschild Asset Management (France)'s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $279K in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Edmond de Rothschild Asset Management (France)'s 13F filing for Q4 2015, filed 16 Feb 2016.